Optimal Hydrocortisone Delivery Mode in Adrenal Crisis During Major Stress
The most clinically appropriate mode of hydrocortisone administration during major stress in patients with adrenal insufficiency is continuous intravenous hydrocortisone.
All articles by Amit Akirov, MD
Bone-Targeted Exercise Strategies to Reduce Fracture Risk in Men
High-intensity progressive resistance and impact training is a well-tolerated program that may improve bone mineral density and physical function in older men.
Are Glycemic Measures in the Nondiabetic Range Linked to NAFLD?
Increased blood glucose levels, even within the nondiabetic range, are associated with increased risk for nonalcoholic fatty liver disease.
Diabetes Negatively Affects Pain Severity and Mental Status in Osteoarthritis
Patients with osteoarthritis and diabetes experience greater knee pain and worse physical and mental status compared with patients without diabetes.
Prognostic Importance of Advanced Pathological Features in Papillary Thyroid Microcarcinoma
Patients presenting with papillary thyroid microcarcinoma could harbor advanced pathological features that are not easily detectable and may have important prognostic value.
Dalcetrapib Reduces Incident Diabetes in Patients With Acute Coronary Syndrome
Dalcetrapib may have clinical utility in the prevention or delay of diabetes in patients with acute coronary syndrome.
Proton Pump Inhibitors Use and Osteoporotic Fracture Risk in Older Women
Treatment with proton pump inhibitors is associated with increased risk for osteoporotic fracture compared with the use of histamine-2 receptor antagonists.
Management of Glucocorticoid-Induced Osteoporosis: An Overview
A major adverse effect of glucocorticoid treatment is significant bone loss, which is most pronounced in the first 3 to 6 months of use.
Suboptimal Adherence to ACE Inhibitors, Statins in Adolescents With Type 1 Diabetes
Although medication adherence to both angiotensin-converting enzyme inhibitors and statins is initially high in adolescents with type 1 diabetes, it frequently deteriorates over time.
Is There a Role for Short-Acting Exenatide in Type 1 Diabetes?
Short-acting preprandial exenatide as an add-on to insulin treatment in patients with type 1 diabetes had no clinically relevant effects on glycemic control or other glycemic measures.
Next post in Type 1 Diabetes
